190012-95-4 Usage
Chemical structure
A complex structure consisting of a spirocyclic ring system with a carboxylic acid and a methylthio propyl ester functional group attached to it.
Potential applications
The compound has potential applications in the pharmaceutical and agrochemical industries due to its unique structure and properties.
Safety guidelines
It is important to handle this chemical with care and follow safety guidelines to minimize any potential hazards associated with its use.
Functional groups
The compound contains a carboxylic acid functional group and a methylthio propyl ester functional group.
Molecular weight
The molecular weight of the compound is approximately 279.4 g/mol.
Physical properties
The physical properties of the compound, such as its melting point, boiling point, and solubility, are not provided in the material.
Reactivity
The reactivity of the compound with other chemicals or under different conditions is not provided in the material.
Stability
The stability of the compound under different conditions, such as temperature, pressure, and exposure to light, is not provided in the material.
Toxicity
The toxicity of the compound and any potential health hazards associated with its use are not provided in the material.
Check Digit Verification of cas no
The CAS Registry Mumber 190012-95-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,0,0,1 and 2 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 190012-95:
(8*1)+(7*9)+(6*0)+(5*0)+(4*1)+(3*2)+(2*9)+(1*5)=104
104 % 10 = 4
So 190012-95-4 is a valid CAS Registry Number.
190012-95-4Relevant academic research and scientific papers
Pharmaceutically active compounds
-
, (2008/06/13)
Compounds of formula (I) wherein: R1 and R19 independently represent hydrogen, alkyl C1-6, alkoxy C1-6, alkylthio C1-6, halogen, hydroxyl or amino; R2 represents H or alkyl; R3 represents phenyl, a 6-membered heterocyclic aromatic ring containing one or two nitrogen atoms, or a 5-membered heterocyclic aromatic ring containing 1 to 3 heteroatoms selected from O,N, and S, which phenyl or heterocyclic aromatic ring may be optionally substituted by alkyl C1-6, alkoxy C1-6, haologen, hydroxyl, alkylthio C1-6, cyano, trifluoromethyl, nitro, hydroxymethyl, amino, a group --(CH2)c NHCO2 R10, a group --(CH2)c NR5 R6, or a group --CO2 R11 ; or R3 represents hydrogen or alkyl C1-8, which alkyl group may be optionally substituted by amino or a group --NHCO2 R10 ; R4 represents hydrogen or alkyl C1-6; or R3 and R4 taken together represent a group (CH2)a Z(CH2)b ; c represents an integer 0 to 2; and pharmaceutically acceptable salts thereof, have been found to be useful as a pharmaceuticals. The compounds may especially be used in the treatment of inflammatory disorders.
